TKNO Stock Overview
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally.
Alpha Teknova, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$4.55|
|52 Week High||US$22.31|
|52 Week Low||US$3.02|
|1 Month Change||21.01%|
|3 Month Change||1.34%|
|1 Year Change||-73.99%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-81.80%|
Recent News & Updates
|TKNO||US Life Sciences||US Market|
Return vs Industry: TKNO underperformed the US Life Sciences industry which returned -27.3% over the past year.
Return vs Market: TKNO underperformed the US Market which returned -19.6% over the past year.
|TKNO Average Weekly Movement||13.8%|
|Life Sciences Industry Average Movement||11.7%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: TKNO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: TKNO's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Alpha Teknova, Inc. Fundamentals Summary
|TKNO fundamental statistics|
Is TKNO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TKNO income statement (TTM)|
|Cost of Revenue||US$23.29m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.34|
|Net Profit Margin||-86.67%|
How did TKNO perform over the long term?See historical performance and comparison